US FDA Announces Recall Of Vitruvias Therapeutics' Thyroid Tablets Over Super Potency

US FDA Announces Recall of Vitruvias Therapeutics' Thyroid Tablets Over Super Potency

Credit: FDA/iStock

Text

Updated Aug 25, 2026 | 10:36 AM IST

SummaryConsumption of superpotent thyroid tablets can cause hyperthyroidism (overactive thyroid). Elderly people,pregnant women and infants with prolonged use are at high risk.

End of Article